In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio

MOUNTAIN VIEW, Calif., May 20, 2013 /PRNewswire-iReach/ -- Today at American Society for Microbiology conference, award lecturer Dr. Christine Ginocchio discussed Specific Technologies blood culture system as an upcoming solution for rapid identification of microorganisms producing bloodstream infection. Dr. Ginocchio is the Senior Medical Director and Chief of the Division of Infect...

Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria

MOUNTAIN VIEW, Calif., May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, today announced the publication of results of the first study demonstrating detection of pathogenic bacteria, including potential bioterrorism agents such as Yersinia pestis and Bacillus anthracis which feature on the Center for Disease Control and Prevention's list of potential bio-threats. This semi...

Quest acquires Concentra's toxicology and clinical laboratory assets

Quest Diagnostics has acquired the toxicology and clinical laboratory business of medical center operator Concentra.

Ariosa Diagnostics Expands Harmony Prenatal Test to Twin Pregnancies and Launches New X,Y Analysis Test

New Innovations to the Harmony Prenatal Test Now Allow for X,Y Analysis and Twin Pregnancies. San Jose, Calif. (PRWEB) May 20, 2013 Ariosa Diagnostics, maker of the non-invasive Harmony™ Prenatal Test for risk assessment of Down syndrome and other chromosome conditions, has announced today the expanded indication for testing of twin pregnancies naturally conceived or conceived using the patien...

CardioDx Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus® CAD Test Influenced Cardiologists' Clinical Management of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease

PALO ALTO, Calif., May 20, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced the publication of the IMPACT-CARD (Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern) trial in Critical Pathways in Cardiology. This prospective study conducted at Vanderbilt University Medical Cente...

OvaScience Co-Founder Recognized in Boston Globe 100’s “The Innovators” Feature

Company also named among Boston’s 50 on Fire OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today announced that OvaScience Co-Founder Jonathan L. Tilly, Ph.D., has been named to The Boston Globe’s 2013 “

Thermo Fisher Scientific Releases New Small Benchtop Centrifuge

Provides scientists with outstanding capacity in a compact design Thermo Fisher Scientific Inc., the world leader in serving science, has launched the new Thermo Scientific small benchtop centrifuge, delivering, in a compact footprint, the flexibility to adapt to evolving clinical and research needs alike, including clinical chemistry, cell culture, mi...

AB SCIEX Announces In Vitro Diagnostic Devices CE Marked for Europe

Company to meet European regulatory requirements for use in clinical laboratories and hospitals AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe. Meeting regulatory requirements to obtain the CE-IVDD mark for the new AB SCIEX API 3...

Proteomics Market - Mass Spectrometry & Biochips 2017 Forecast & Analysis in New Research Report at ReportsnReports.com

“Proteomics: Technologies and Global Markets” is the new market research report added to ReportsnReports.com store. Dallas, Texas (PRWEB) May 20, 2013 The main objective for the present report is to present the up-to-date market picture for proteomics into a single comprehensive report. The objective was to capture the changing industry dynamics and market shift occurring in this industry....

Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)

CHAPEL HILL, N.C., May 20, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, today announced that it presented data at the American Thoracic Society International Conference (ATS 2013) in Philadelphia demonstrating the antibacterial and e...

Asmacure Highlights Four Presentations on Novel Pulmonary Development Compound ASM-024 Presented at American Thoracic Society 2013 International Conference

QUEBEC CITY, May 20, 2013 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced presentations of four studies of ASM-024, Asmacure's lead compound in development for asthma and chronic obstructive pulmonary disease (COPD). Th...

BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC™ Stem Cell Therapy Device

JUPITER, Fla., May 20, 2013  /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announces the signing of a consulting agreement with Dexterity, Inc. ("Dexterity"). Dexterity is a product design and bioengineering firm that will pro...

Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2

PHILADELPHIA and REHOVOT, Israel, May 20, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company has executed a credentialing agreement with Prime Health Services, Inc. (Prime Health), a managed care company that offers a full spectrum of services, including a Preferred...

Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico

CARLSBAD, Calif., May 20, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems™ 3500 Dx and 3500xL Dx Genetic Analyzers have been approved by the Federal Commission for Protection against Health Risks in Mexico for diagnostic use.  The development marks a major extension of Life Technologies' capabilities to serve the clinica...

Amarantus to Present at the 2nd Annual Marcum MicroCap Conference on May 30

SUNNYVALE, Calif., May 20, 2013 /PRNewswire/ -- Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced that Chief Executive Officer Gerald Commissiong will present at the 2nd Annual Marcum MicroCap Conference on Thursday, May 30, 2013, at the...

Collaboration Aims to Create In Vitro Human Skin

Affymetrix Appoints Gavin Wood as Executive Vice President and Chief Financial Officer

A seasoned financial leader with extensive international experience Affymetrix, Inc. (NASDAQ: AFFX) today announced it has appointed Mr. Gavin Wood to the position of Executive Vice President and Chief Financial Officer. Mr. Wood joined Affymetrix in 2006 and served most recently as VP Finance, International Controller based in the United Kingdom....

NICE Medtech Innovation Briefings To Support Med Device Development

Précis:  NICE have announced the publication a new set of briefings designed to increase uptake of innovative medical devices and technologies within the NHS, driven by concerns that patients are not...

AB SCIEX launches 3200MD CE-IVDD series in Europe for in vitro diagnostic use

AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.

The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris

On 25-28 July, 2013, UPCP 2013 will convene once again, this time – in Paris - the beautiful city of lights. Paris, France (PRWEB) May 20, 2013 On 25-28 July, 2013, UPCP 2013 will convene once again, this time – in Paris - the beautiful city of lights. According to Prof. Eddy Karnieli, the congress chairperson, "Personalized Medicine is revolutionizing the medical world. Understanding an...

How Much Do Drug Companies Spend on R&D, Anyway?

How much does Big Pharma spend on R&D, compared to what it takes in? This topic came up during a discussion here last week, when a recent article at The Atlantic referred to these expenditures as "only" 16 cents on the dollar, and I wanted to return...

CardioDx Announces New Data Demonstrating Use of Corus® CAD in the Primary Care Setting for Evaluation of Symptomatic Patients with Suspected CAD Influences Clinical Decision Making

PALO ALTO, Calif., May 17, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a clinical utility study of the Corus® CAD gene expression test in the real-world primary care setting for evaluating patients with signs and symptoms suggestive of obstructive coronary artery disease (CAD). The multicenter, prospective study...

Blood Banking Market Trends and Opportunities for Suppliers

DALLAS, May 17, 2013 /PRNewswire-iReach/ -- ReportsnReports.com offers new blood banking market research reports for UK, France, Germany, Italy, Spain, US and Japan covering information on industry outlook, innovations, trends and opportunities for suppliers. (Photo: http://photos.prnewswire.com/prnh/20130517/CG16214) These blood banking market reports provide information and data individually f...

Quest Diagnostics completes acquisition of Concentra's toxicology and clinical laboratory business

Quest Diagnostics, the world's leading provider of diagnostic information services, announced today that it has acquired the toxicology and clinical laboratory business of medical center operator Concentra, a subsidiary of Humana Inc.

Erba Diagnostics financial update